Targeting glioblastoma with a brain-penetrant drug that impairs brain tumor stem cells via NLE1-Notch1 complex. - Burban A; Sharanek A; Hernandez-Corchado A; Najafabadi HS; Soleimani VD; Jahani-Asl A (Stem cell reports, 2024)